Air Liquide, Europe’s leader in home healthcare, continues to develop its home healthcare activity in Spain, a high potential market. The acquisition of the startup DiaLibre in Spain reinforces Air Liquide's service offering throughout the diabetic patient's care pathway, from the distribution of medical equipment to the personalized support of diabetic patients. Air Liquide Healthcare already provides home healthcare services for 1.6 million patients worldwide with chronic diseases and is developing new home healthcare models designed to improve their quality of life.
Air Liquide has acquired Spain’s DiaLibre, a startup that specializes in diabetes care. Its offering combines personalized therapeutic support programs and medical follow-up for patients using innovative technologies. DiaLibre connects experts - doctors, nurses, dieticians, psychologists - with patients in order to offer improved daily support. During the first visit, the DiaLibre specialist initiates with the patient the treatment prescribed by the physician and defines the best tailored program to their lifestyle. The personalized plan includes access to online learning programs and educational videos, in addition to remote consultation tools including dietary tips, and psychological support to help them manage their chronic disease on a daily basis. This support aims at improving patient adherence to care over the long term.
Air Liquide has already been operating in the Spanish healthcare market for more than 50 years, and has been present in diabetes since 2016 via its subsidiary Novalab, which supports patients with type 1 and type 2 diabetes. With this offering, Air Liquide is now positioned to offer personalized services at every step in the treatment process for diabetic patients.
François Jackow, member of the Air Liquide Group’s Executive Committee, supervising Healthcare activities stated:
"We are pleased to welcome the DiaLibre teams, recognized for their medical, technological, and digital expertise. This acquisition allows us to complete our offer, which seeks to improve the quality of life for our patients by giving them access to the most appropriate approach based on their profile, which is key for patient’s engagement to his treatment. With this acquisition, it will be possible to test and integrate new complementary care models into our offerings. It also opens up new development prospects for the home healthcare business in Europe.”
Supplies medical gases, home healthcare services, hygiene products, medical equipment and specialty ingredients.
In 2018, it served over 15,000 hospitals and clinics and more than 1.6 million patients at home throughout the world. The Group’s Healthcare business reached €3,486 million in revenues in 2018, with the support of its 16,500 employees.
Air Liquide, European leader in home healthcare, provides home healthcare services in compliance with medical prescription for patients suffering from chronic diseases such as COPD (Chronic Obstructive Pulmonary Disease), sleep apnea and diabetes. These home healthcare services are being developed in addition to hospital care, enabling patients to enjoy a better quality of life and local authorities to reduce costs. Home healthcare represents 45% of Air Liquide's revenue in Healthcare in 2018.